Welcome to the ARAPC website

Arthritis & Rheumatism Associates, P.C., is the largest Rheumatology practice in the Washington, D.C., area. For more than 30 years, the group has served this community and has been dedicated to the diagnosis and treatment of persons with disorders of the joints, muscles, tendons, and other connective tissue. Our practice has treatment centers in Wheaton, Rockville, Chevy Chase and Olney, Maryland, and in Northwest Washington, DC.

Our practice integrates excellent medical care with comprehensive services. We maintain a full-service laboratory, x-ray facilities, a physical therapy division, four centers for the diagnosis and treatment of osteoporosis and four infusion centers. We offer patients the opportunity to access the most recent and innovative technologies by maintaining an active clinical research program that participates in national trials to evaluate new medications for the treatment of arthritis, osteoporosis, and a variety of rheumatic diseases. VIEW PHYSICIAN BIOS >

Are you interested in Clinical Trials?

The Center for Rheumatology and Bone Research is a division of Arthritis and Rheumatism Associates, a 15-physician rheumatology practice. The Center was developed to give our patients access to the most recent therapies for the treatment of rheumatic diseases through participation in clinical trials. We began running clinical trials in 1982 and have since participated in the evaluation of new agents for Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Sjögren’s syndrome, Fibromyalgia, tendinitis and Ankylosing Spondylitis. We remain committed to the evaluation of investigational treatments for all of the rheumatic diseases. Our research center is located in Wheaton, MD, on the grounds of Westfield Shoppingtown Wheaton. The Center is easily accessible by car, bus or subway.

ARAPC’s New location

ARA has a new office in Olney, MD that opened May 5th, 2015. Paul DeMarco, MD, Guada Respicio, MD and Dan El-Bogdadi, MD are seeing patients transitioning from Dr. Knitzer’s practice prior to our new space on MedStar Montgomery Medical Center’s campus in August 2015.

LATEST NEWS

Patient
Announcement:We are now infusing Entyvio (vedolizumab), which is approved by the FDA for the treatment of Crohn's disease and ulcerative colitis. Our rheumatologists can accept infusion orders from your gastroenterologist, and you can be treated in any one of our five convenient locations.